TY - JOUR
T1 - Predicting amyloid risk by machine learning algorithms based on the A4 screen data
T2 - Application to the Japanese Trial-Ready Cohort study
AU - Sato, Kenichiro
AU - Ihara, Ryoko
AU - Suzuki, Kazushi
AU - Niimi, Yoshiki
AU - Toda, Tatsushi
AU - Jimenez-Maggiora, Gustavo
AU - Langford, Oliver
AU - Donohue, Michael C.
AU - Raman, Rema
AU - Aisen, Paul S.
AU - Sperling, Reisa A.
AU - Iwata, Atsushi
AU - Iwatsubo, Takeshi
N1 - Publisher Copyright:
© 2021 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association
PY - 2021
Y1 - 2021
N2 - Background: Selecting cognitively normal elderly individuals with higher risk of brain amyloid deposition is critical to the success of prevention trials for Alzheimer's disease (AD). Methods: Based on the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease study data, we built machine-learning models and applied them to our ongoing Japanese Trial-Ready Cohort (J-TRC) webstudy participants registered within the first 9 months (n = 3081) of launch to predict standard uptake value ratio (SUVr) of amyloid positron emission tomography. Results: Age, family history, online Cognitive Function Instrument and CogState scores were important predictors. In a subgroup of J-TRC webstudy participants with known amyloid status (n = 37), the predicted SUVr corresponded well with the self-reported amyloid test results (area under the curve = 0.806 [0.619–0.992]). Discussion: Our algorithms may be usable for automatic prioritization of candidate participants with higher amyloid risks to be preferentially recruited from the J-TRC webstudy to in-person study, maximizing efficiency for the identification of preclinical AD participants.
AB - Background: Selecting cognitively normal elderly individuals with higher risk of brain amyloid deposition is critical to the success of prevention trials for Alzheimer's disease (AD). Methods: Based on the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease study data, we built machine-learning models and applied them to our ongoing Japanese Trial-Ready Cohort (J-TRC) webstudy participants registered within the first 9 months (n = 3081) of launch to predict standard uptake value ratio (SUVr) of amyloid positron emission tomography. Results: Age, family history, online Cognitive Function Instrument and CogState scores were important predictors. In a subgroup of J-TRC webstudy participants with known amyloid status (n = 37), the predicted SUVr corresponded well with the self-reported amyloid test results (area under the curve = 0.806 [0.619–0.992]). Discussion: Our algorithms may be usable for automatic prioritization of candidate participants with higher amyloid risks to be preferentially recruited from the J-TRC webstudy to in-person study, maximizing efficiency for the identification of preclinical AD participants.
UR - http://www.scopus.com/inward/record.url?scp=85108911971&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108911971&partnerID=8YFLogxK
U2 - 10.1002/trc2.12135
DO - 10.1002/trc2.12135
M3 - Article
AN - SCOPUS:85108911971
SN - 2352-8737
VL - 7
JO - Alzheimer's and Dementia: Translational Research and Clinical Interventions
JF - Alzheimer's and Dementia: Translational Research and Clinical Interventions
IS - 1
M1 - e12135
ER -